Table of Contents Table of Contents
Previous Page  667 / 1173 Next Page
Information
Show Menu
Previous Page 667 / 1173 Next Page
Page Background

1/03/2016

6

EGFR as target (Cetuximab)

Cetuximab (c225)

The landmark trial

Bonner et al NEJM 2006

Bonner Lancet Oncol 2010